Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma

Cancer Research

Volumn 57, Issue 5, 1997, Pages 907-912

  Takita, Junko ^a,b   Hayashi, Yasuhide ^b   Kohno, Takashi ^a   Yamaguchi, Naohito ^a   Hanada, Ryoji ^c   Yamamoto, Keiko ^c   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 9; CHROMOSOME MAP; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MISSENSE MUTATION; NEUROBLASTOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, MYC; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; INFANT; MICROSATELLITE REPEATS; NEUROBLASTOMA; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROMOTER REGIONS (GENETICS); RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031030343     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Weinberg, R. A. Tumor suppressor genes, Science (Washington DC), 254: 1138-1146, 1991.
2. Yokota, J., and Sugimura, T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J., 7: 920-925, 1993.
3. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., and Brodeur, G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
4. Suzuki, T., Yokota, J., Mugishima, H., Okabe, I., Ookuni, M., Sugimura, T., and Terada, M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res., 49: 1095-1098, 1989.
5. Fong, C. T., White, P. S., Peterson, K., Sapienza, C., Cavenee, W. K., Kern, S. E., Vogelstein, B., Cantor, A. B., Look, A. T., and Brodeur, G. M. Loss of heterozygosity for chromosomes 1 and 14 defines subsets of advanced neuroblastoma. Cancer Res., 52; 1780-1785, 1992.
6. Takayama, H., Suzuki, T., Mugishima, H., Fujisawa, T., Ookuni, M., Schwab, M., Gehring, M., Nakamura, Y., Sugimura, T., Terada, M., and Yokota, J. Deletion map of chromosome 14q and 1p in neuroblastoma. Oncogcnc, 7: 1185-1189, 1992.
7. Caron, H., van Sluis, P., van Hoeve, M., de Kraker, J., Bras, J., Slater, R., Mannens, M., Voute, P. A., Westerveld, A., and Versteeg, R. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat. Genet., 4: 187-190, 1993.
8. Srivatsan, E. S., Ying, K. L., and Seeger, R. C. Deletion of chromosome 11 and 14q sequences in neuroblastoma. Genes Chromosomes Cancer, 7: 32-37, 1993.
9. Schleiermacher, G., Peter, M., Michon, J., Hugot, J-P., Vielh, P., Zucker, J-M., Magdelenat, H., Thomas, G., and Delattre, O. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer. 10: 275-281, 1994.
10. Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., and Kaneko, Y. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtype of neuroblastoma. Genes Chromosomes Cancer, 10: 30-39, 1994.
11. Tonini, G. P. Neuroblastoma: a multiple biological disease. Eur. J. Cancer, 29A: 802-804, 1993.
12. Takita, J., Hayashi, Y., Kohno, T., Shiseki, M., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Allelotype of neuroblastoma. Oncogene, 11: 1829-1834, 1995.
13. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-438, 1994.
14. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.). 368: 753-756, 1994.
15. INK4B / MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 53: 382-387, 1995.
16. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/M/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
17. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P, J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55; 4525-4530, 1995.
18. Evans, A. E., D'Angio, G. J., and Randolph, J. A proposed staging for children with neuroblastoma. Cancer (Phila.), 27: 374-378, 1971.
19. Ota, K., and Shimizu, K. Histological Classification and Atlas of Tumors in Infancy and Child: a Report from the Committee on the Histological Classification of Childhood Tumors of the Japanese Pathological Society. Tokyo: Kanahara Publisher, 1980.
20. Maniatis, T., Fritsch, F. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982,
21. Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizuguchi, H., Sugimura, T., Terada, M., and Yokota, J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes small-cell lung carcinoma. Oncogene, 7:451-457, 1992.
22. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutation in familial melanoma. Nat. Genet., 8: 15-12, 1994.
23. Ookawa, K., Sakamoto, M., Hirohashi, S., Yoshida, Y., Sugimura, T., Terada, M., and Yokota, J. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int. J. Cancer, 53; 382-387, 1993.
24. Cannon-Albright, L. A., Golgar, D. E., Meyer, L. J., Green, R., MacLennan, N. G., Martin, L. J., and Kamb, A. Assignment of a locus for familial melanoma, MLM, to chromosome 9pl3-22. Science (Washington DC), 258: 1148-1152, 1993.
25. Paul, C., Tokino, K., Eby, Y., and Sidransky, D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinoma. Cancer Res., 55; 224-227, 1995.
26. Merlo, A., Gabrielson, E., Askin, F., and Sidransky, D. Frequent loss of chromosone 9 in human primary non-small cell lung cancer. Cancer Res., 54: 640-642, 1994.
27. Ruppert, J. M., Tokino, K., and Sidransky, D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res., 55; 5093-5095. 1995.
28. Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54; 1156-1158, 1994.
29. Schultz, D. C., Vanderveer, L., Buetow, K. H., Boente, M. P., Ozols, R. F., Hamilton, T. C., and Godwin, A. K. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res., 55; 2150-2157, 1995.
30. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinoma, Cancer Res., 55: 224-227, 1995.
31. Miura, N., Okita, K., Furukawa, Y., Matsuno S., and Nakamura, Y. Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-cencimorgan interval of the distal long arm of chromosome 9. Cancer Res., 55; 1828-1830, 1995.
32. Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M., and Brodeur, G. M. No CDKN2 mutation in neuroblastomas. Cancer Res., 55; 2053-2055, 1995.
33. INK4B1. Cancer Res., 56: 722-727, 1996.
34. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and pl5 gene in brain tumors. Cancer Res., 54; 6353-6358, 1995.